Cargando…

Functional analysis of polymorphisms at the S1/S2 site of SARS-CoV-2 spike protein

Several SARS-CoV-2 variants emerged that harbor mutations in the surface unit of the viral spike (S) protein that enhance infectivity and transmissibility. Here, we analyzed whether ten naturally-occurring mutations found within the extended loop harboring the S1/S2 cleavage site of the S protein, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arora, Prerna, Sidarovich, Anzhalika, Graichen, Luise, Hörnich, Bojan, Hahn, Alexander, Hoffmann, Markus, Pöhlmann, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956166/ https://www.ncbi.nlm.nih.gov/pubmed/35333910 http://dx.doi.org/10.1371/journal.pone.0265453

Ejemplares similares

SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies
por: Arora, Prerna, et al.
Publicado: (2022)

SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
por: Hoffmann, Markus, et al.
Publicado: (2021)

Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance
por: Arora, Prerna, et al.
Publicado: (2021)

Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy
por: Hoffmann, Markus, et al.
Publicado: (2022)

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
por: Hoffmann, Markus, et al.
Publicado: (2021)

Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1
por: Sidarovich, Anzhalika, et al.
Publicado: (2022)

B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination
por: Arora, Prerna, et al.
Publicado: (2021)

The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency
por: Arora, Prerna, et al.
Publicado: (2021)

Mutation D614G increases SARS-CoV-2 transmission
por: Arora, Prerna, et al.
Publicado: (2021)

Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
por: Arora, Prerna, et al.
Publicado: (2022)

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
por: Arora, Prerna, et al.
Publicado: (2022)

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
por: Hoffmann, Markus, et al.
Publicado: (2020)

SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation
por: Hörnich, Bojan F., et al.
Publicado: (2021)

SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination
por: Arora, Prerna, et al.
Publicado: (2022)

No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
por: Arora, Prerna, et al.
Publicado: (2022)

The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
por: Arora, Prerna, et al.
Publicado: (2022)

SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications
por: Schlör, Anja, et al.
Publicado: (2022)

SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization
por: Hoffmann, Markus, et al.
Publicado: (2021)

Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage
por: Arora, Prerna, et al.
Publicado: (2023)

Novel SARS-CoV-2 receptors: ASGR1 and KREMEN1
por: Hoffmann, Markus, et al.
Publicado: (2021)

Understanding Omicron: Transmissibility, immune evasion and antiviral intervention
por: Hoffmann, Markus, et al.
Publicado: (2022)

Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein
por: Kleine-Weber, Hannah, et al.
Publicado: (2018)

Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein
por: Budhadev, Darshita, et al.
Publicado: (2023)

Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein
por: Xing, Yue, et al.
Publicado: (2020)

Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage
por: Nehlmeier, Inga, et al.
Publicado: (2023)

Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2
por: Reinke, Lennart Michel, et al.
Publicado: (2017)

The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
por: Arora, Prerna, et al.
Publicado: (2022)

Sphingosine prevents binding of SARS–CoV-2 spike to its cellular receptor ACE2
por: Edwards, Michael J., et al.
Publicado: (2020)

Systematical assessment of the impact of single spike mutations of SARS-CoV-2 Omicron sub-variants on the neutralization capacity of post-vaccination sera
por: Katzmarzyk, Maeva, et al.
Publicado: (2023)

Thiol drugs decrease SARS-CoV-2 lung injury in vivo and disrupt SARS-CoV-2 spike complex binding to ACE2 in vitro
por: Khanna, Kritika, et al.
Publicado: (2021)

Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5
por: Hoffmann, Markus, et al.
Publicado: (2023)

LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
por: Shilts, Jarrod, et al.
Publicado: (2023)

Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2
por: Priya, Prerna, et al.
Publicado: (2021)

Site-specific glycan analysis of the SARS-CoV-2 spike
por: Watanabe, Yasunori, et al.
Publicado: (2020)

The Emergence of the Spike Furin Cleavage Site in SARS-CoV-2
por: Chan, Yujia Alina, et al.
Publicado: (2021)

Emergence of SARS‐CoV‐2 spike protein at the vaccination site
por: Beck, Annika, et al.
Publicado: (2023)

The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways
por: Laporte, Manon, et al.
Publicado: (2021)

Priming Time: How Cellular Proteases Arm Coronavirus Spike Proteins
por: Hoffmann, Markus, et al.
Publicado: (2018)

SARS-CoV-2 spike and its adaptable furin cleavage site
por: Whittaker, Gary R
Publicado: (2021)

Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation
por: Allen, Joel D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gm67rt8f6vjh84jc7ruflec90s